ALNY is off more than 40% in the past year and has an enterprise value of only $200M. Does anyone here find the stock attractive at this valuation? They reported 1Q11 results today: http://finance.yahoo.com/news/Alnylam-Pharmaceuticals-bw-1042593757.html?x=0&.v=1 .